Rocket Pharmaceuticals (RCKT) Total Debt (2014)

Rocket Pharmaceuticals' (RCKT) quarterly Total Debt came in at $3.0 million in Q4 2014.

Rocket Pharmaceuticals (RCKT) Total Debt (2014) Analysis & Trends

Rocket Pharmaceuticals has disclosed Total Debt across 1 years of filings, most recently posting $3.0 million for Q4 2014.

Total Debt for Q4 2014 came in at $3.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was $3.0 million (changed N/A YoY), and the FY2014 annual result was $3.0 million, changed N/A from the prior year.
Total Debt came in at $3.0 million for Q4 2014 at Rocket Pharmaceuticals.
In the past five years, Total Debt ranged from a high of $3.0 million in Q4 2014 to a low of $3.0 million in Q4 2014.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	319.10 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Rocket Pharmaceuticals	301.08 Mn	301.08 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2014	3.03 Mn